Researchers say certain oral diabetes drugs reduce cancer risk in women

[Northerner]

A class of oral diabetes medications that has drawn controversy in recent years reduces the risk of cancer in women taking it by almost a third, says a large new study conducted by researchers at the Cleveland Clinic.

In preventing cancer, the researchers found that insulin sensitizers, including the drugs metformin, rosiglitazone and pioglitazone (the latter two marketed as Avandia and Actos) were more powerful than insulin secretagogues such as glyburide, glipizide and glimepiride.

http://medcitynews.com/2013/12/clev...oral-diabetes-drugs-reduce-cancer-risk-women/